Phase one trial explores novel immunotherapy for breast cancer

A groundbreaking phase one clinical trial exploring a novel cell-based immunotherapy for breast cancer has been accepted for publication in JAMA Oncology.

Medicare has different standards than the FDA. That’s how it should be

Who among us is looking forward to getting older in 2024? Not senators (most of whom are 65 and older), the two leading presidential candidates

February 2, 2024

Pharmalittle: We’re reading about Trump orders and public health, AI startups overstating their work, and more

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of online

February 10, 2025

Medacta’s QUADRA-H hip stem achieves 13A* exemplary quality rating from the British Orthopaedic Data Evaluation Panel (ODEP) – Biotech Investments

Medacta Group SA / Key word(s): Miscellaneous Medacta’s QUADRA-H hip stem achieves 13A* exemplary quality rating from the British Orthopaedic Data Evaluation Panel (ODEP) 08.01.2024

January 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.